Literature DB >> 9198348

The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic.

D G Armstrong1, W F Todd, L A Lavery, L B Harkless, T R Bushman.   

Abstract

The aim of this longitudinal study was to report on the clinical characteristics and treatment course of acute Charcot's arthropathy at a tertiary care diabetic foot clinic. Fifty-five diabetic subjects, with a mean age of 58.6 +/- 8.5 years, were studied. All patients were treated with serial total contact casting until quiescence. Following casting and before transfer to prescription footwear, patients were eased into unprotected weightbearing via a removable cast walker. This cohort was followed for their entire treatment course and for a mean 92.6 +/- 33.7 weeks following return to shoes. Pain was the most frequent presenting complaint in these otherwise insensate patients (76%). The mean duration of casting was 18.5 +/- 10.6 weeks. Patients returned to footwear in a mean 28.3 +/- 14.5 weeks. Nine per cent of the population had bilateral arthropathy. These subjects were casted significantly longer than the unilateral group (p < 0.02). Surgery was performed on 25% of patients, with approximately two-thirds of these procedures involving plantar exostectomies and one-third fusions of affected joints. Patients receiving surgery remained casted significantly longer than non-surgical patients (p < 0.05). Additionally, men were casted longer than women (p < 0.008). Acute Charcot's arthropathy requires prompt, uncompromising reduction in weightbearing stress. Our data show that the ambulatory total contact cast is very effective for this. Regardless of the specific treatment method instituted, it is imperative that appropriate and aggressive treatment be undertaken immediately following diagnosis to help prevent progression to a profoundly debilitating, limb-threatening deformity.

Entities:  

Mesh:

Year:  1997        PMID: 9198348     DOI: 10.7547/87507315-87-6-272

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  19 in total

1.  Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus.

Authors:  Virna Zampa; Irene Bargellini; Loredana Rizzo; Francesca Turini; Simona Ortori; Alberto Piaggesi; Carlo Bartolozzi
Journal:  Skeletal Radiol       Date:  2011-01-28       Impact factor: 2.199

2.  Tarsal and metatarsal bone mineral density measurement using volumetric quantitative computed tomography.

Authors:  Paul K Commean; Tao Ju; Lu Liu; David R Sinacore; Mary K Hastings; Michael J Mueller
Journal:  J Digit Imaging       Date:  2008-05-14       Impact factor: 4.056

3.  [Diagnostic for Charcot foot].

Authors:  S G Hofstaetter; K Trieb
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

4.  A Candidate Imaging Marker for Early Detection of Charcot Neuroarthropathy.

Authors:  Paul K Commean; Kirk E Smith; Charles F Hildebolt; Kathryn L Bohnert; David R Sinacore; Fred W Prior
Journal:  J Clin Densitom       Date:  2017-06-28       Impact factor: 2.617

5.  Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports.

Authors:  David J Gutekunst; David R Sinacore
Journal:  J Orthop Sports Phys Ther       Date:  2013-09-09       Impact factor: 4.751

6.  Progression of foot deformity in Charcot neuropathic osteoarthropathy.

Authors:  Mary K Hastings; Jeffrey E Johnson; Michael J Strube; Charles F Hildebolt; Kathryn L Bohnert; Fred W Prior; David R Sinacore
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

7.  Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes.

Authors:  Philippe Hernigou; Isaac Guissou; Yasuhiro Homma; Alexandre Poignard; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2015-03-22       Impact factor: 3.075

Review 8.  Measurement of somatic neuropathy for clinical practice and clinical trials.

Authors:  L V Scott; S Tesfaye
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  [Reconstructive surgery for Charcot foot. Long-term 5-year outcome].

Authors:  U Illgner; M Podella; M Rümmler; J Wühr; H G Büsch; H H Wetz
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

Review 10.  [Charcot foot. Current situation and outlook].

Authors:  T Mittlmeier; K Klaue; P Haar; M Beck
Journal:  Unfallchirurg       Date:  2008-04       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.